Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-12

Clinical Trial Update: Duration of GnRH-analogue Downregulation and Pregnancy Rates [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the duration of GnRH-analogue downregulation and its effect on pregnancy rates in infertility was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH analogue (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Infertility | Phase 4 | Status: TERMINATED